title: Abraxane-induced cystoid macular edema refractory to concomitant intravenous bevacizumab.
authors.forename: Darrell E
authors.initials: DE
authors.lastname: Baskin
authors.forename: Sunir J
authors.initials: SJ
authors.lastname: Garg
mesh_terms: D000328:Adult; D000068196:Albumin-Bound Paclitaxel; D000418:Albumins / Q000009:adverse effects; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007275:Injections, Intravenous; D008269:Macular Edema / Q000139:chemically induced* / Q000188:drug therapy; D017239:Paclitaxel / Q000009:adverse effects*; D012008:Recurrence; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D000068196:Albumin-Bound Paclitaxel; D000418:Albumins; D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D017239:Paclitaxel